We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.72B
AUM Growth
+$403M
Cap. Flow
+$53M
Cap. Flow %
0.93%
Top 10 Hldgs %
15.98%
Holding
769
New
66
Increased
305
Reduced
281
Closed
46

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$44.4M
2
PG icon
Procter & Gamble
PG
+$30.3M
3
BIDU icon
Baidu
BIDU
+$26.3M
4
BMY icon
Bristol-Myers Squibb
BMY
+$22.2M
5
LLY icon
Eli Lilly
LLY
+$22.1M

Sector Composition

Rank Sector Weight
1 Healthcare 27.14%
2 Technology 13.76%
3 Financials 13.55%
4 Consumer Discretionary 9.45%
5 Communication Services 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RETA
451
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1.87M 0.03%
+60,000
New +$1.8M
PXD
452
DELISTED
Pioneer Natural Resource Co.
PXD
$1.85M 0.03%
12,553
-2,006
-14% -$288K
LVLT
453
DELISTED
Level 3 Communications Inc
LVLT
$1.84M 0.03%
34,533
-1,207
-3% -$67.2K
HBAN icon
454
Huntington Bancshares
HBAN
$35.1B
$1.84M 0.03%
131,698
+22,520
+21% +$296K
CFG icon
455
Citizens Financial Group
CFG
$30.4B
$1.84M 0.03%
48,516
-75,627
-61% -$2.65M
FRC
456
DELISTED
First Republic Bank
FRC
$1.84M 0.03%
17,582
+1,504
+9% +$149K
L icon
457
Loews
L
$24.3B
$1.83M 0.03%
38,272
+1,378
+4% +$65.6K
WY icon
458
Weyerhaeuser
WY
$17.3B
$1.81M 0.03%
53,291
+1,721
+3% +$56.5K
EXPD icon
459
Expeditors International
EXPD
$22.9B
$1.79M 0.03%
29,891
-802
-3% -$45.9K
DELL icon
460
Dell
DELL
$283B
$1.79M 0.03%
82,471
-31,146
-27% -$600K
BXP icon
461
Boston Properties
BXP
$11B
$1.78M 0.03%
14,478
+1,536
+12% +$186K
BALL icon
462
Ball Corp
BALL
$17B
$1.78M 0.03%
43,002
+31,742
+282% +$1.3M
SYRS
463
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.77M 0.03%
+12,000
New +$2.26M
NOV icon
464
NOV
NOV
$7.45B
$1.75M 0.03%
49,022
+1,788
+4% +$58.4K
PBA icon
465
Pembina Pipeline
PBA
$29.9B
$1.75M 0.03%
49,874
-6,514
-12% -$217K
COL
466
DELISTED
Rockwell Collins
COL
$1.72M 0.03%
13,181
-1,114
-8% -$135K
NSTG
467
DELISTED
NanoString Technologies, Inc.
NSTG
$1.71M 0.03%
106,000
+61,000
+136% +$941K
RARX
468
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$1.69M 0.03%
116,000
+35,000
+43% +$529K
PARA
469
DELISTED
Paramount Global Class B
PARA
$1.68M 0.03%
29,001
-67,290
-70% -$4.25M
SBAC icon
470
SBA Communications
SBAC
$18.4B
$1.68M 0.03%
11,639
-8,025
-41% -$1.14M
OMED
471
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$1.67M 0.03%
370,000
+156,000
+73% +$632K
DVA icon
472
DaVita
DVA
$15.1B
$1.66M 0.03%
28,000
RHT
473
DELISTED
Red Hat Inc
RHT
$1.62M 0.03%
14,621
+1,137
+8% +$116K
MHK icon
474
Mohawk Industries
MHK
$6.9B
$1.61M 0.03%
6,500
+5,236
+414% +$1.3M
ADM icon
475
Archer Daniels Midland
ADM
$41.4B
$1.58M 0.03%
37,142
-7,000
-16% -$295K

Similar funds

Candriam SCA's Q3 2017 Portfolio in Review

As of Q3 2017, Candriam SCA held 769 positions worth $5.72B, up 7.6% from $5.32B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA's Q3 2017 filing shows 66 new, 305 increased, 281 reduced and 46 closed positions. Its largest new stake was Alaska Air: 139,079 shares worth $10.6M. The largest sale was GE Aerospace, an estimated $30.7M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2017 buy was Alaska Air: 139,079 shares worth $10.6M.
  • Candriam SCA added most to Microsoft in Q3 2017, an estimated $44.4M increase.
  • Candriam SCA's biggest Q3 2017 reduction was GE Aerospace, cutting an estimated $30.7M.
  • Candriam SCA fully exited Staples Inc in Q3 2017, selling an estimated $26.4M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.72B portfolio in Q3 2017.
  • Candriam SCA opened 66 new positions and closed 46 in Q3 2017.
  • Candriam SCA's portfolio value rose 7.6% quarter-over-quarter to $5.72B.

Based on Candriam SCA's 13F filing for Q3 2017, filed 3 Nov 2017.